Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Characterization of Occult Hepatitis B Virus Infection Among Iranian Patients With Behcet’S Disease; Correlation With Clinical Status Publisher



Shahram F1 ; Ghorbani S2 ; Mahmoudi M1 ; Akhlaghi M1 ; Jadali Z3 ; Imeni V1 ; Norouzi M4 ; Faezi ST1 ; Monavari SHR2 ; Mostafaei S5 ; Poortahmasebi V4 ; Barfi S4 ; Alavian SM6 ; Jazayeri SM7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Rheumatology Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Virology, Iran University of Medical Sciences, Tehran, Iran
  3. 3. Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Hepatitis B laboratory, Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Community Medicine, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
  6. 6. MELD Center, Tehran, Iran
  7. 7. Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran

Source: Hepatitis Monthly Published:2021


Abstract

Background: Behcet’s disease (BD) is a chronic multisystem vasculitis with an unknown etiology. During the past years, several reports are published on the occult hepatitis B infection (OBI), the presence of hepatitis B virus (HBV) DNA in the absence of HBsAg, in rheumatic diseases. Objectives: The current study aimed to, firstly, investigate the prevalence of OBI in patients with BD, and, secondly, its potential association with the clinical and therapeutic status of BD. Methods: HBV serological markers and HBV DNA were evaluated in 220 consecutive BD patients to detect OBI. Demographic and clinical data of OBI positive and negative groups were compared. Results: The mean age of patients was 39.24 (± 10.57), and 134 (62.9%) were male. The mean disease duration was 14.13 (± 8.63) years. No HBsAg positive case was found, but HBV DNA was found in 19 (8.6%) patients. The median viral load value was 475.84 copy/mL. We compared clinical data of 10 OBI positive and 156 OBI negative BD patients with complete and accessible data. There was no difference between the two groups concerning demographic characteristics (age, sex, and disease duration), different clinical manifestations, or types of medications (immunomodulatory, cytotoxic, and corticosteroids). Conclusions: This is the first study showing a rather high prevalence of OBI among BD patients. We did not find any correlation between OBI positivity and different clinical manifestations, medications, or HLA-B51. Further studies are needed on a larger group of patients and by molecular HBV evaluation (as well as serologic) regarding this possible association. © 2021, Author(s).